BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18006815)

  • 1. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
    Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
    Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.
    Nomura S; Nakajima A; Ishimine S; Matsuhashi N; Kadowaki T; Kaminishi M
    J Exp Clin Cancer Res; 2006 Sep; 25(3):443-8. PubMed ID: 17167986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
    Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
    Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
    Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
    Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
    Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
    Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
    Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
    Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
    J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential.
    Yamamichi N; Yamamichi-Nishina M; Mizutani T; Watanabe H; Minoguchi S; Kobayashi N; Kimura S; Ito T; Yahagi N; Ichinose M; Omata M; Iba H
    Oncogene; 2005 Aug; 24(35):5471-81. PubMed ID: 16007216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-specific expression of chromatin remodeling factor BRM.
    Itoh T; Miyake K; Iijima S
    Biochem Biophys Res Commun; 2008 Feb; 366(3):827-33. PubMed ID: 18082132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
    Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
    Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.
    Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N
    Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
    Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
    Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
    Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
    J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.